InterCure Begins 2022 with Record Breaking First Quarter Financial Results
May 16, 2022 17:50 ET
|
InterCure Ltd.
Record revenue of $341 million in the first quarter of 2022 Adjusted EBITDA2 increased almost 110% year-over-year to $8 million Net income of $6 million for the Q1 of 2022 compared to $2...
ABVC Biopharma Reports First Quarter 2022 Financial and Operational Results
May 16, 2022 17:46 ET
|
ABVC BioPharma, Inc.
FREMONT, CA, May 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire--ABVC BioPharma, Inc. (Nasdaq: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
Skylight Health Group Reports First Quarter 2022 Financial Results
May 16, 2022 17:33 ET
|
Skylight Health Group Inc.
TORONTO, May 16, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States,...
Visionary Education Technology Holdings Group Inc. Announces Pricing of US$17 Million Firm Commitment Initial Public Offering
May 16, 2022 17:33 ET
|
Visionary Education Technology Holdings Group Inc.
Markham, Ontario, May 16, 2022 (GLOBE NEWSWIRE) -- Visionary Education Technology Holdings Group Inc. (the “Company”), a private education provider located in Canada that offers high-quality...
Comstock Reports First Quarter 2022 Results
May 16, 2022 17:27 ET
|
Comstock Holding Companies, Inc.
Revenue increased 28% to $8.7 million in Q1 2022 vs. $6.8 million in Q1 2021Net income from continuing operations of $2.0 million in Q1 2022 vs. $0.4 million in Q1 2021Adjusted EBITDA increased $1.0...
PyroGenesis Announces Q1 2022 Results: Revenues $4.2MM; Gross Margin 25%; Current Backlog of Signed and/or Awarded Contracts $41.2MM
May 16, 2022 17:20 ET
|
PyroGenesis Canada Inc.
MONTREAL, May 16, 2022 (GLOBE NEWSWIRE) -- PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY), a high-tech company (hereinafter referred to as the “Company” or...
Aerovate Therapeutics Presents Phase 1 Data for AV-101, A Novel Dry Powder Inhaled Formulation of Imatinib Being Developed for the Treatment of Patients with Pulmonary Arterial Hypertension (PAH)
May 16, 2022 17:15 ET
|
Aerovate Therapeutics, Inc.
AV-101 is being developed to address cellular hyperproliferation and resistance to apoptosis in the pulmonary vasculature, which are key features of the pathophysiology of PAH PAH is an area of high...
Quipt Home Medical Reports Record Second Quarter Fiscal 2022 Financial Results
May 16, 2022 17:06 ET
|
Quipt Home Medical Corp.
Posts Revenue Growth of 38% and Adjusted EBITDA Growth of 31% Reiterates Outlook for Calendar Year End 2022 CINCINNATI, May 16, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”)...
Alkami to Present at Upcoming Investor Conferences
May 16, 2022 17:05 ET
|
Alkami Technology, Inc.
PLANO, Texas, May 16, 2022 (GLOBE NEWSWIRE) -- Alkami Technology, Inc. (Nasdaq: ALKT) (“Alkami”), a leading cloud-based digital banking solutions provider for U.S. banks and credit unions, today...
Autoscope Technologies Corporation Announces Financial Results
May 16, 2022 17:05 ET
|
Autoscope Technologies Corporation
MINNEAPOLIS, May 16, 2022 (GLOBE NEWSWIRE) -- Autoscope Technologies Corporation (Nasdaq: AATC) today announced results for its quarter ended March 31, 2022. First Quarter 2022 Financial Summary ...